Global Cannabis Testing Market

1 INTRODUCTION OF GLOBAL CANNABIS TESTINGMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CANNABIS TESTINGMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL CANNABIS TESTING MARKET, BY END USER
5.1 Product & Software
5.1.1 Laboratories
5.1.2 Small-Scale Laboratories
5.1.3 Medium-Scale Laboratories
5.1.4 Large-Scale Laboratories
5.2 Research Institutions
5.3 Services
5.3.1 Cannabis Drug Manufacturers & Dispensaries
5.3.2 Cannabis Cultivators/Growers

6 GLOBAL CANNABIS TESTING MARKET, BY PRODUCT AND SOFTWARE
6.1 Cannabis Testing product
6.1.1 Analytical Instruments
6.1.1.1 Chromatography
6.1.1.2 Spectroscopy
6.1.2 Consumables
6.1.2.1 Chromatography Columns
6.1.2.2 Standards and CRMS
6.1.2.3 Sample Preparation Products
6.1.2.4 Supplies and Accessories
6.2 Cannabis Testing Software

7 GLOBAL CANNABIS TESTING MARKET, BY TYPE
7.1 Potency Testing
7.2 Terpene Profiling
7.3 Residual Solvent Screening
7.4 Microbial Analysis
7.5 Pesticide Screening
7.6 Heavy Metal Testing
7.7 Genetic Testing

8 GLOBAL CANNABIS TESTINGMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL CANNABIS TESTINGMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Agilent Technologies, Inc.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Shimadzu Corporation
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Millipore Sigma (A Life Science Segment of Merck KGaA)
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Restek Corporation
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Perkinelmer, Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 AB Sciex LLC (A Subsidiary of Danaher Corporation)
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Waters Corporation
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Accelerated Technology Laboratories, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Steep Hill Halent Laboratories, Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Digipath, Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 SC (Science of Cannabis) Laboratories, Inc.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Pharmlabs LLC
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

11 Appendix
11.1 Related Reports